President Donald Trump referenced the announcement the following day in Oval Office remarks, framing AstraZeneca’s overall ...

The company will build a multi-billion-dollar drug manufacturing center in Virginia that will focus on chronic diseases, as ...

Researchers at NYU Tandon School of Engineering have developed a new method for creating microscopic drug delivery capsules ...

Biogen has announced plans to invest an additional $2bn in Research Triangle Park (RTP) in the US state of North Carolina.

Aprecia, the global leader in 3DP (three-dimensional print) technology for commercial-scale pharmaceutical manufacturing, today announced that the U.S. Food and Drug Administration (FDA) has approved ...

Gov. Glenn Youngkin announced Monday that pharmaceutical giant AstraZeneca will build its largest single manufacturing ...

Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced the successful close of its Series C financing round at an increased ...

Bizerba joins Körber’s PAS-X Weigh & Dispense programme as new partner: Balingen, Germany Tuesday, July 22, 2025, 15:00 Hrs [IST] Bizerba, a global leader in industrial scales ...

The Fortune 500 company based in Cambridge, Mass., opened its first campus in the Research Triangle Park in 1995.

Cambridge UK headquartered pharma giant AstraZeneca is investing $50 billion across the US in the next five years, dodging ...

AstraZeneca AZN has unveiled a sweeping $50 billion investment plan in the United States, to be executed by 2030. The ...

As many as 3,104 drugs were found to be “not of standard quality” while 245 were found to be spurious out of 1,16,323 drug samples tested between April 2024 and March 2025, the Rajya Sabha was ...